Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-24-278124
Filing Date
2024-12-13
Accepted
2024-12-13 11:07:45
Documents
10
Period of Report
2024-12-13

Document Format Files

Seq Description Document Type Size
1 6-K d913939d6k.htm 6-K 9899
2 EX-99.1 d913939dex991.htm EX-99.1 12961
3 EX-99.2 d913939dex992.htm EX-99.2 38941
4 EX-99.3 d913939dex993.htm EX-99.3 42685
5 EX-99.4 d913939dex994.htm EX-99.4 19435
6 GRAPHIC g913939g05k61.jpg GRAPHIC 1440
7 GRAPHIC g913939g1213103418819.jpg GRAPHIC 2601
8 GRAPHIC g913939g1213103419632.jpg GRAPHIC 2610
9 GRAPHIC g913939g27p67.jpg GRAPHIC 1374
10 GRAPHIC g913939g99b84.jpg GRAPHIC 1277
  Complete submission text file 0001193125-24-278124.txt   138699
Mailing Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017
Business Address 46 AVENUE DE LA GRANDE ARMEE PARIS I0 75017 33153774400
Sanofi (Filer) CIK: 0001121404 (see all company filings)

EIN.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-31368 | Film No.: 241547230
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)